Key result
Mechanical overload of living myocardial slices reduced contractility to 3.53 mN mm/C02 compared to 7.48 mN mm/C02 at physiological load, and induced fibrotic remodeling that was prevented by a TGF-βR blocker.
Why the study?
Altered mechanical load drives myocardial fibrosis, but no existing in vitro model can precisely modulate load in a multicellular environment while preserving physiological behaviour.
Does mechanical overload induce fibrotic remodeling and reduced contractility in living myocardial slices, and can it be modulated by TGF-βR blockade?
Does mechanical overload induce fibrotic remodeling and reduced contractility in living myocardial slices, and can it be modulated by TGF-βR blockade?
Absolute Event Rate: 3.53% vs 7.48%
Living myocardial slices provide a viable in vitro platform to study mechanosensitive fibrotic remodeling, demonstrating that mechanical overload induces fibrosis and contractile dysfunction that can be mitigated by TGF-βR blockade.
LMS overload induces YAP-driven fibrosis modulable by TGF-βR blockade; leaves open in vivo validation before therapeutic translation.
Aims Altered mechanical load in response to injury is a main driver of myocardial interstitial fibrosis. No current in vitro model can precisely modulate mechanical load in a multicellular environment while maintaining physiological behaviour. Living myocardial slices (LMS) are a 300 μm-thick cardiac preparation with preserved physiological structure and function. Here we apply varying degrees of mechanical preload to rat and human LMS to evaluate early cellular, molecular, and functionality changes related to myocardial fibrosis. Methods and results Left ventricular LMS were obtained from Sprague Dawley rat hearts and human cardiac samples from healthy and failing (dilated cardiomyopathy) hearts. LMS were mounted on custom stretchers and two degrees of diastolic load were applied: physiological sarcomere length (SL) (SL = 2.2 μm) and overload (SL = 2.4 μm). LMS were maintained for 48 h under electrical stimulation in circulating, oxygenated media at 37°C. In overloaded conditions, LMS displayed an increase in nucleus translocation of Yes-associated protein (YAP) and an up-regulation of mechanotransduction markers without loss in cell viability. Expression of fibrotic and inflammatory markers, as well as Collagen I deposition were also observed. Functionally, overloaded LMS displayed lower contractility (7.48 ± 3.07 mN mm−2 at 2.2 SL vs. 3.53 ± 1.80 mN mm−2 at 2.4 SL). The addition of the profibrotic protein interleukin-11 (IL-11) showed similar results to the application of overload with enhanced fibrosis (8% more of collagen surface coverage) and reduced LMS contractility at physiological load. Conversely, treatment with the Transforming growth factor β receptor (TGF-βR) blocker SB-431542, showed down-regulation of genes associated with mechanical stress, prevention of fibrotic response and improvement in cardiac function despite overload (from 2.40 ± 0.8 mN mm−2 to 4.60 ± 1.08 mN mm−2). Conclusions The LMS have a consistent fibrotic remodelling response to pathological load, which can be modulated by a TGF-βR blocker. The LMS platform allows the study of mechanosensitive molecular mechanisms of myocardial fibrosis and can lead to the development of novel therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Núñez-Toldrà et al. (2022) studied Myocardial fibrosis. Mechanical overload (sarcomere length 2.4 μm) vs. Physiological load (sarcomere length 2.2 μm) was evaluated on Contractility (mN mm/C02). Mechanical overload of living myocardial slices reduced contractility to 3.53 mN mm/C02 compared to 7.48 mN mm/C02 at physiological load, and induced fibrotic remodeling that was prevented by a TGF-βR blocker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: